Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

Mark Dawson

5 posts
RRoche
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Read More

Change to the Roche Enlarged Corporate Executive Committee

  • 2026-04-30
F. Hoffmann-La Roche Ltd Basel, 17 February 2026 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the…
RRoche
Roche appoints Mark Dawson as new Head of Pharma Research and Early Development
Read More

Roche appoints Mark Dawson as new Head of Pharma Research and Early Development

  • 2026-04-02
People Roche appoints Mark Dawson as new Head of Pharma Research and Early Development Dawson joins Roche from…
RRoche
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
Read More

Change to the Roche Enlarged Corporate Executive Committee

  • 2026-02-18
F. Hoffmann-La Roche Ltd Basel, 17 February 2026 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the…
RRoche
Roche fenebrutinib Phase III hits PPMS disability goal
Read More

Roche appoints Mark Dawson to lead pRED unit

  • 2026-02-17
Roche (OTCQX: RHHBY) announced Mark Dawson, M.D., Ph.D., will become Head of Roche…
RRoche
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
Read More

Change to the Roche Enlarged Corporate Executive Committee

  • 2026-02-17
F. Hoffmann-La Roche Ltd Basel, 17 February 2026 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the…
Switzerland
www.europesays.com